The top dose produced 20.9% average weight loss over 72 weeks and 20.2% in a direct comparison with semaglutides 13.7%. Its second receptor, GIP, separates tirzepatide from approved single-receptor GLP-1 drugs and helps explain the larger population-level weight loss. That 20.9% came from participants averaging about 105 kg at a BMI of 38, most of whom were sedentary
Ozempic and Mounjaro are FDA-approved for diabetes and all states cover them for that use
You will see some results after the second bottle
If you notice persistent brain fog, fatigue, or mental sluggishness, pay attention to patterns in your diet, hydration, and sleep
En una encuesta (en ingls) de diciembre del 2023 de la Universidad de Mchigan se encontr que ms del 60% de los adultos con sobrepeso de entre 50 y 80 aos estn interesados en tomar uno
I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last